Mar 6, 2017 | Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Laboratory Testing
Since most patients do not accurately report what they eat, a new medical laboratory test could provide doctors and researchers with the ‘first independent indicator of the quality of a person’s diet’
It may soon be possible to measure the health of a person’s diet by use of a 5-minute diagnostic test recently developed by British scientists. The test can reveal the facts about how well a person eats and has the potential to find clinical value among medical professionals and in clinical laboratories.
What adds to the interest in this test is the widespread incidence of obesity in most developed nations around the world. It would be a useful tool for medical professionals who have wanted better ways to manage this health problem. (more…)
Feb 27, 2017 | Coding, Billing, and Collections, Compliance, Legal, and Malpractice, Digital Pathology, Instruments & Equipment, Laboratory Hiring & Human Resources, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Laboratory Sales and Marketing, Laboratory Testing, Managed Care Contracts & Payer Reimbursement, Management & Operations
The DxMA Summit’s agenda will complement EWC’s and will explore disruptive technologies likely to be of great interest to medical laboratory leaders and pathology groups
Cybersecurity, wearable technology, and social media are the primary trends facing in vitro diagnostics (IVD) manufacturers and clinical laboratories.
That’s according to Debra Harrsch, President-elect of the Diagnostics Marketing Association (DxMA), a self-funded organization devoted to helping diagnostic marketing professionals stay abreast of industry trends and effectively navigate the changing legal, regulatory, and technology landscape.
DxMA will be holding its annual Global Marketing Summit April 30-May 1 at the Sheraton New Orleans Hotel on Canal Street. Coincidentally, the 2017 Executive War College (EWC) will takes place in the same venue, May 2-3, directly following the DxMA summit. (more…)
Feb 13, 2017 | Digital Pathology, Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology
Innovative technological advances could potentially provide clinical laboratories, pathology groups, and medical researchers with improved methodologies for designing, performing, and analyzing lab tests that use genetic information
Researchers at the University of Texas at Austin (UT Austin) have developed an innovative new enzyme that promises to improve the methods and tools used by pathology groups and clinical laboratories when conducting genetic testing.
The enzyme enables the reproduction of large quantities of Ribonucleic acid (RNA) to be accurately duplicated. It also can perform reverse transcription and scrutinize itself while copying genetic information, which will enable both researchers and clinical laboratories to improve the accuracy of gene sequencing where RNA is involved.
The team published their findings in Science, the academic journal of The American Association for the Advancement of Science (AAAS) and filed for a provisional patent for the new sequence of the discovered enzyme. (more…)
Feb 1, 2017 | Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Laboratory Testing
EarlyCDT-Lung test followed by X-rays and CT scans proves up to five times more likely to detect cancer than current standard of care
Encouraging preliminary results from a 12,000-person clinical trial into the effectiveness of a non-invasive medical laboratory blood test for the early detection of lung cancer could signal an advance that leads to creation of similar anatomic pathology screening tests for the early detection of other cancers.
Interim results of a study using the potentially life-saving blood test EarlyCDT-Lung were presented on December 6, 2016, at the International Association for the Study of Lung Cancer’s 17th World Conference on Lung Cancer in Vienna, Austria. Initial results from the trial indicated the blood test can detect lung cancer potentially up to five years before symptoms develop. (more…)
Jan 27, 2017 | Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory News, Laboratory Operations, Laboratory Pathology, Management & Operations
To match the supply of blood products to demand, a clever entrepreneur has created an award-winning business that may help clinical laboratories better manage the cost of blood products in their hospitals and health systems
There’s something new and exciting in the world of blood banking and medical laboratory medicine. It’s a unique approach to matching the availability of blood products to the demand for those same products and it’s catching the attention of medical laboratory directors and blood bankers in many of the nation’s hospitals.
How did an ice storm and a Super Bowl factor into the development of an innovative and disruptive technology that addresses a persistent gap in the US blood products supply chain? In February 2011, central Texas was hit by fierce weather that not only disrupted flights, snarled traffic, and threatened Super Bowl XLV, it also impacted the local and regional hospitals’ ability to access blood for patients in need. Enter a young entrepreneur who saw a critical problem and understood that the raw materials for a solution already existed. (more…)
Jan 25, 2017 | Instruments & Equipment, Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory Pathology, Laboratory Testing
A new blood test for concussion demonstrates how multiple metabolomic biomarkers have the potential to be used by medical laboratories for diagnostic testing purposes
Medical laboratories and pathology groups will soon see new blood tests that measure hundreds of biomarkers. One such test is being developed by Children’s Health Research Institute, a Lawson Health Research Institute program, and Western University in Ontario, Canada. This test, based on metabolomics, has been shown to be 90% accurate for diagnosing concussion in preliminary studies.
In an article published on Brainline.org, an organization dedicated to the prevention and treatment of traumatic brain injuries (TBIs), Melissa Duff, PhD, Assistant Professor in the Department of Communication Sciences and Disorders and the Department of Neurology at the University of Iowa, wrote, “The risk of concussion is highest in the 15- to 19-year-old age group. In addition, males are at higher risk than females.” Thus, the Lawson team focused on developing a test for the group that is most at-risk for concussion—adolescent males. (more…)
